A61K 38/1796
For hormones
Official title: {for hormones (for neuromediators A61K38/1787)}
A61K38/1796 (For hormones) appears on 127 US grants and 289 published applications in this corpus.
Search patents in A61K- Granted patents
- 127
- Published applications
- 289
- Assignees
- 123
- Inventors
- 439
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 5 |
| 2005 | 1 | 4 |
| 2006 | 2 | 8 |
| 2007 | 1 | 3 |
| 2008 | 0 | 6 |
| 2009 | 4 | 16 |
| 2010 | 3 | 13 |
| 2011 | 4 | 8 |
| 2012 | 8 | 6 |
| 2013 | 4 | 8 |
| 2014 | 2 | 4 |
| 2015 | 5 | 11 |
| 2016 | 6 | 9 |
| 2017 | 5 | 14 |
| 2018 | 9 | 17 |
| 2019 | 7 | 15 |
| 2020 | 14 | 29 |
| 2021 | 15 | 28 |
| 2022 | 11 | 17 |
| 2023 | 5 | 20 |
| 2024 | 7 | 19 |
| 2025 | 7 | 11 |
| 2026 | 4 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Liquid formulation22 Sep 2026US 12,741,011 B2Hanmi Pharm. Co., Ltd.
- Methods and composition for modulating immune response and immune homeostasis11 Aug 2026US 12,702,696 B2Massachusetts Institute of Technology
- Methods and devices for treating a disease with biotherapeutics16 Jun 2026US 12,653,992 B2BT Bidco, Inc.
- Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases28 Apr 2026US 12,611,401 B2Pfizer Inc.
- I domain chimeric antigen receptor specific to ICAM-19 Sep 2025US 12,410,235 B2Cornell University
- Gene therapy8 Oct 2026US 2026/0308598 A1
- Methods and devices for treating a disease with biotherapeutics10 Sep 2026US 2026/0263766 A1
- Nucleic acid construct coding for insulin receptor fragment and use thereof20 Aug 2026US 2026/0242446 A1Tokyo Metropolitan Institute of Medical Science
- Use of bmp receptor alk1 inhibitors in osteoarthritis therapies13 Aug 2026US 2026/0234217 A1The Regents of the University of California
- Combinations Comprising Benzodioxol as GLP-1R Agonists for Use in the Treatment of NASH/NAFLD and Related Diseases30 Jul 2026US 2026/0216152 A1Pfizer Inc.
Most cited
By later US patents
- Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions198US 7,048,906 B2Cedars-Sinai Medical Center · 2006
- ActRII receptor polypeptides, methods and compositions121US 7,709,605 B2Acceleron Pharma Inc. · 2010
- Method of increasing red blood cell levels or treating anemia in a patient94US 8,058,229 B2Acceleron Pharma Inc. · 2011
- Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators93US 8,216,997 B2Acceleron Pharma Inc. · 2012
- Activin-ActRII antagonists and uses for increasing red blood cell levels92US 7,988,973 B2Acceleron Pharma Inc. · 2011